The Changing Face of Liver Transplantation in the United States: The Effect of HCV Antiviral Eras on Transplantation Trends and Outcomes

BACKGROUND: Hepatitis C virus (HCV) cirrhosis is the leading indication for liver transplantation in the United States, although nonalcoholic steatohepatitis (NASH) is on the rise. Increasingly effective HCV antivirals are available, but their association with diagnosis-specific liver transplantatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Parrish, Nicholas F., Feurer, Irene D., Matsuoka, Lea K., Rega, Scott A., Perri, Roman, Alexopoulos, Sophoclis P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Liver Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411219/
https://www.ncbi.nlm.nih.gov/pubmed/30882032
http://dx.doi.org/10.1097/TXD.0000000000000866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411219/
https://www.ncbi.nlm.nih.gov/pubmed/30882032
http://dx.doi.org/10.1097/TXD.0000000000000866

Ejemplares similares